Report ID :10321884 |
Published Date : 21 Oct 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
Global Influenza Diagnostics Market is valued approximately at USD 646.5 million in 2019 and is anticipated to grow with a growth rate of more than 7.8% over the forecast period 2020-2026. Influenza is an infectious respiratory infection caused via flu viruses. Each year seasonal influenza affects millions of people leading thousands of hospitalizations and flu-related deaths. As per the World Health Organization report 2019, every year there are an estimated 1 billion cases Influenza, about 3-5 million severe cases of influenza, and 290 000-650 000 influenza-associated respiratory deaths worldwide. Influenza outbreaks have encouraged healthcare authorities across the world to upsurge the capacity of influenza diagnosis, which is further contributing towards the adoption of influenza diagnostics. Global influenza diagnostic market growth is mainly driven by aspects such as the growing incidence of influenza, growing in research funding for influenza diagnostics, and the growing demand for faster diagnosis. Furthermore, the increasing approvals of influenza diagnostic products by governing authorities is expected to create significant growth opportunity for the market over the forecast period. For instance, Abbott Laboratories received FDA clearance for ID NOW Influenza A & B 2 Assay product in 2018. Similarly, Quidel Corporation received FDA clearance for QuickVue Influenza A+B Test product. However, complex regulatory framework for the approval of new diagnostic tests impedes the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Influenza Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increasing prevalence of influenza and advanced healthcare facilities in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as developing healthcare infrastructure, increasing prevalence of diseases would create lucrative growth prospects for the Influenza Diagnostics market across Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Hologic Inc.
Becton, Dickinson, and Company
DiaSorin S.p.A
Luminex Corporation
Meridian Bioscience Inc.
GenMark Diagnostics
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Test type:
Traditional Diagnostic Tests
Molecular Diagnostic Tests
By End user:
Hospitals
Clinical Laboratories
Other End-User
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Influenza Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
